Abstract
Fibromyalgia is a common syndrome characterized by generalized pain present for greater than 3 months, joint stiffness, fatigue, mood disorders, cognitive dysfunction, nonrestorative sleep, and tender points.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Smythe HA, Moldofsky H. Two contributions to understanding of the “fibrositis” syndrome. Bull Rheum Dis. 1977–1978;28(1):928–31.
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–72.
Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547–55.
Williams DA, Clauw DJ. Understanding fibromyalgia: lessons from the broader pain research community. J Pain. 2009;10(8):777–91.
Staud R, Smitherman M. Peripheral and central sensitization in fibromyalgia: pathogenetic role. Curr Pain Headache Rep. 2002;6(4):259–66.
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62(5):600–10.
Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, Blonna D. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012:426130.
Busch AJ, Barber KAR, Overend TJ, Peloso PMJ, Schachter CL. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev. 2007;(4):CD003786.
Bernardy K, Klose P, Busch AJ, Choy EHS, Häuser W. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013;(9):CD009796.
Simons DG. Muscular pain syndromes. In: JR Fricton, EA Award (Eds.), Myofascial pain and fibromyalgia, Advances in pain research and therapy (2nd ed.), Raven Press, New York, vol. 17. 1990. p. 1–41.
Giamberardino MA, Affaitati G, Fabrizio A, Costantini R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol. 2011;25(2):185–98.
Simons DG, Travell JG, Simons LS. Travell and Simons’ myofascial pain and dysfunction: the trigger point manual. vol 1. Upper half of body. 2nd ed. Baltimore: Williams & Wilkins; 1999.
Maihöfner C, Seifert F, Markovic K. Complex regional pain syndromes: new pathophysiological concepts and therapies. Eur J Neurol. 2010;17(5):649–60.
Cossins L, Okell RW, Cameron H, Simpson B, Poole HM, Goebel A. Treatment of complex regional pain syndrome in adults: a systematic review of randomized controlled trials published from June 2000 to February 2012. Eur J Pain. 2013;17(2):158–73.
Badalamente MA, Hurst LC, Ellstein J, McDevitt CA. The pathobiology of human neuromas: an electron microscopic and biochemical study. J Hand Surg Br. 1985;10(1):49–53.
Brogan DM, Kakar S. Management of neuromas of the upper extremity. Hand Clin. 2013;29(3):409–20.
Worrell M. Dupuytren’s disease. Orthopedics. 2012;35(1):52–60.
Desai SS, Hentz VR. The treatment of Dupuytren disease. J Hand Surg Am. 2011;36(5):936–42.
Darowish M, Sharma J. Evaluation and treatment of chronic hand conditions. Med Clin North Am. 2014;98(4):801–15.
Garcia RA, Inwards CY, Unni KK. Benign bone tumors-recent developments. Semin Diagn Pathol. 2011;28:73–85.
Sinelnikov A, Kale H. Osteochondromas of the spine. Clin Radiol. 2014;69:e584–90.
Motamedi K, Seeger LL. Benign bone tumors. Radiol Clin North Am. 2011;49:1115–34.
Qasem SA, DeYoung BR. Cartilage-forming tumors. Semin Diagn Pathol. 2014;31(1):10–20.
Amanatullah DF, Clark TR, Lopez MJ, Borys D, Tamurian RM. Giant cell tumor of bone. Orthopedics. 2014;37(2):112–20.
Schwab JH, Springfield DS, Raskin KA, Mankin HJ, Hornicek FJ. What’s new in primary malignant musculoskeletal tumors. J Bone Joint Surg Am. 2013;95(24):2240–6.
HaDuong JH, Martin AA, Skapek SX, Mascarenhas L. Sarcomas. Pediatr Clin North Am. 2015;62(1):179–200.
Schwab JH, Springfield DS, Raskin KA, Mankin HJ, Hornicek FJ. What’s new in primary bone tumors. J Bone Joint Surg Am. 2012;94(20):1913–9.
Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin Sarcoma Res. 2012;2(1):14.
Donaldson SS. Ewing sarcoma: radiation dose and target volume. Pediatr Blood Cancer. 2004;42(5):471–6.
Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009;115(7):1531–43.
Henderson TO, Rajaraman P, Stovall M, Constine LS, Olive A, Smith SA, et al. Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. Int J Radiat Oncol Biol Phys. 2012;84(1):224–30.
Shimose S, Kubo T, Fujimori J, Furuta T, Ochi M. A novel assessment method of serum alkaline phosphatase for the diagnosis of osteosarcoma in children and adolescents. J Orthop Sci. 2014;19(6):997–1003. doi:10.1007/s00776-014-0617-0.
Chen J, Sun MX, Hua YQ, Cai ZD. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis. J Cancer Res Clin Oncol. 2014;140(7):1205–10.
Miller BJ, Cram P, Lynch CF, Buckwalter JA. Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database. J Bone Joint Surg Am. 2013;95(13):e89.
van Maldegem AM, Bovée JV, Gelderblom H. Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013. Clin Sarcoma Res. 2014;4:11.
Ollivier L, Vanel D, Leclère J. Imaging of chondrosarcomas. Cancer Imaging. 2003;4(1):36–8.
Fuji H, Nakasu Y, Ishida Y, Horiguchi S, Mitsuya K, Kashiwagi H, et al. Feasibility of proton beam therapy for chordoma and chondrosarcoma of the skull base. Skull Base. 2011;21(3):201–6.
Ferraresi V, Nuzzo C, Zoccali C, Marandino F, Vidiri A, Salducca N, Zeuli M, Giannarelli D, Cognetti F, Biagini R. Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients. BMC Cancer. 2010;10:22.
Coleman R. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20 Pt 2):6243s–9s.
Ohmori K, Matsui H, Yasuda T, Kanamori M, Yudoh K, Seto H, Tsuji H. Evaluation of the prognosis of cancer patients with metastatic bone tumors based on serial bone scintigrams. Jpn J Clin Oncol. 1997;27(4):263–7.
Bowers LM, Cohen DM, Bhattacharyya I, Pettigrew Jr JC, Stavropoulos MF. The non-ossifying fibroma: a case report and review of the literature. Head Neck Pathol. 2013;7(2):203–10.
Shaker JL. Paget’s disease of bone: a review of epidemiology, pathophysiology and management. Ther Adv Musculoskelet Dis. 2009;1(2):107–25.
Arnold LM, Clauw DJ, Dunegan LJ, Turk DC, FibroCollaborative. A framework for fibromyalgia management for primary care providers. Mayo Clin Proc. 2012;87(5):488–96.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this entry
Cite this entry
Chakrabarty, S., Foderingham, N., O’Hara, H. (2017). Selected Disorders of the Musculoskeletal System. In: Paulman, P., Taylor, R., Paulman, A., Nasir, L. (eds) Family Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-04414-9_121
Download citation
DOI: https://doi.org/10.1007/978-3-319-04414-9_121
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-04413-2
Online ISBN: 978-3-319-04414-9
eBook Packages: MedicineReference Module Medicine